ANGO
AngioDynamics, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +3.8% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 44.02K | $609,566 | n/a | −1 |
| Q2 2026 | 72 | +3 | 20.49M | $266.54M | +7 | −4 |
| Q1 2026 | 71 | -1 | 21.06M | $239.47M | +4 | −5 |
| Q4 2025 | 72 | 0 | 22.40M | $287.62M | +1 | −1 |
| Q3 2025 | 18 | 0 | 15.02M | $167.73M | n/a | n/a |
| Q2 2025 | 15 | -1 | 13.76M | $136.51M | n/a | −1 |
| Q1 2025 | 13 | +2 | 6.65M | $62.49M | +2 | n/a |
| Q4 2024 | 11 | 0 | 7.29M | $66.82M | n/a | n/a |
| Q3 2024 | 10 | 0 | 5.47M | $42.55M | n/a | n/a |
| Q2 2024 | 10 | n/a | 5.27M | $31.86M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 2.24M | +24.6% | $17.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 1.06M | -3.7% | $8.22M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 960.77K | +5.1% | $7.48M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Two Sigma Investments ✦ | 352.50K | -27.4% | $2.74M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 304.46K | -1.9% | $2.37M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 6 | D. E. Shaw & Co. ✦ | 218.58K | -31.0% | $1.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 183.45K | +16.4% | $1.43M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 89.51K | +0.2% | $696,388 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 34.54K | +0.6% | $269,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 33.23K | -50.7% | $258,498 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 145 holders, 38.52M shares, $430.26M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.